The action is about developing medical technology solutions in the hospital environment to prevent or reduce “Hospital Associated Infections (HAI)”. With up to 600,000 infections and 20,000 deaths annually in Germany, these are not just a phenomenon of the various corona waves, but a permanent issue. The increase in multi-resistant germs is particularly critical. According to a study by the AMR Industry Alliance, deaths from drug resistance could rise to around 10 million per year worldwide in 2050.
U.S. patent granted to terraplasma, the innovation leader in the development and implementation of cold atmospheric plasma (cold plasma for short) applications. The United States Trademark and Patent Office (USTPO) granted a patent under the number US 11,628,050B2 for the “Apparatus and method for treating objects, in particular teeth and dentures”. The invention relates in detail to a device and method for treating, in particular cleaning objects (in particular dental objects and/or teeth) with so-called “Plasma Activated Water (PAW)”.